Pfizer anticipates revenue growth, driven by oncology investments, M&A activities, and manufacturing optimization. See why ...

We recently published a list of 10 Best Major Stocks to Invest In According to Analysts. In this article, we are going to ...

Exploding sales of prescription weight loss medications have catapulted Novo Nordisk (NVO) and Eli Lilly (LLY) to become the ...

On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 ...

"Pharmacy middlemen" are to blame for the high cost of drugs like Wegovy and Ozempic, according to Novo Nordisk's CEO. Is ...

With the third quarter of 2024 ending, the discourse on the stock market for global equities has shifted back to interest ...

Ozempic-curious people are taking a novel approach to using the blockbuster weight loss drug — and some doctors are even ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...

In the U.K., a pharma-run watchdog has been issuing fines and levying suspensions. Could this help build public trust?

Picture: Therapeutic Goods Administration Photos released by authorities show the first victim’s drug and the seized items — ...

Med en imponerende track record i at sikre vækst og med et fokus på digital strategi og kundecentrerede oplevelser, b ...

Demand forweight-loss drugs has grown at an astonishing rate in recent years, driving share prices of healthcare giants such ...